How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia

International Journal of Drug Policy

Volumn 26, Issue 1, 2015, Pages 43-50

  Horyniak, Danielle ^a,b   Stoové, Mark ^a,b   Degenhardt, Louisa ^c,d   Aitken, Campbell ^a,b   Kerr, Thomas ^e,f   Dietze, Paul ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Australia; Drug markets; Heroin; Initiation; Injecting drug use; Methamphetamine

Indexed keywords

DIAMORPHINE; METHAMPHETAMINE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DEMOGRAPHY; DRUG MARKETING; EXPERIENCE; FEMALE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; MULTIPLE DRUG ABUSE; SELF INJECTION; SELF REPORT; SOCIAL ASPECT; DRUG ABUSE; HARM REDUCTION; INFORMATION PROCESSING; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; SUBSTANCE ABUSE; SUPPLY AND DISTRIBUTION; TIME; YOUNG ADULT;

ADULT; AMPHETAMINE-RELATED DISORDERS; DATA COLLECTION; FEMALE; HARM REDUCTION; HEROIN; HEROIN DEPENDENCE; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MULTIVARIATE ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; VICTORIA; YOUNG ADULT;

EID: 84919632863     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.09.002     Document Type: Article

References (70)

1. Aitken C.K., Higgs P., Bowden S. Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission. Epidemiology and Infection 2008, 136(3):410-416. 10.1017/s0950268807008679.
2. Aitken C.K., Higgs P.G., Hellard M.E. Buprenorphine injection in Melbourne, Australia - An update. Drug and Alcohol Review 2008, 27(2):197-199. pii:790497288. 10.1080/09595230701829553.
3. Aitken C., Moore D., Higgs P., Kelsall J., Kerger M. The impact of a police crackdown on a street drug scene: Evidence from the street. International Journal of Drug Policy 2002, 13(3):193-202.
4. Australian Crime Commission Australian illicit drug data report 1999-2000 2001, Australian Crime Commission, Canberra.
5. Australian Crime Commission Australian illicit drug report 2001-2002 2003, Australian Crime Commission, Canberra.
6. Australian Crime Commission Illicit drug data report 2009-2010 2011, Australian Crime Commission, Canberra.
7. Australian Institute of Criminology Australian crime: Facts and figures 2005 2006, Australian Institute of Criminology, Canberra.
8. Australian Institute of Health and Welfare Alcohol and other drug treatment services in Australia 2010-11: Report on the National Minimum Data Set. Drug Treatment Series Number 18. Cat. No. HSE 128 2012, Australian Institute of Health and Welfare, Canberra.
9. Australian Institute of Health and Welfare National opioid pharmacotherapy statistics annual data collection 2012. Drug treatment series 20. Cat. No. HSE 136 2013, Australian Institute of Health and Welfare, Canberra.
10. Behrens D.A., Caulkins J.P., Tragler G., Feichtinger G. Why present-oriented societies undergo cycles of drug epidemics. Journal of Economic Dynamics and Control 2002, 26(6):919-936. 10.1016/S0165-1889(01)00003-3.
11. Best D., Manning V., Strang J. Retrospective recall of heroin initiation and the impact on peer networks. Addiction Research & Theory 2007, 15(4):397-410. 10.1080/16066350701340651.
12. Caulkins J.P., Reuter P. Illicit drug markets and economic irregularities. Socio-Economic Planning Sciences 2006, 40(1):1-14. 10.1016/j.seps.2004.08.002.
13. Chalmers J., Bradford D., Jones C. The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia. International Journal of Drug Policy 2010, 21(5):381-389. 10.1016/j.drugpo.2010.06.002.
14. Conway K.P., Swendsen J.D., Rounsaville B.J., Merikangas K.R. Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug and Alcohol Dependence 2002, 65(3):225-234. 10.1016/S0376-8716(01)00168-5.
15. Crofts N., Louie R., Rosenthal D., Jolley D. The first hit: Circumstances surrounding initiation into injecting. Addiction 1996, 91(8):1187-1196.
16. Darke S., Hall W., Topp L. The Illicit Drug Reporting System (IDRS) 1996-2000: History and development of a national strategic early warning system for monitoring trends in illicit drug use 2000, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
17. Day C., Degenhardt L., Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug and Alcohol Review 2006, 25(4):307-313. pii:G647387J26L168VP. 10.1080/09595230600741040.
18. Day C.A., Ross J., Dietze P., Dolan K. Initiation to heroin injecting among heroin users in Sydney, Australia: Cross sectional survey. Harm Reduction Journal 2005, 2(1):2. pii:7-7517-2-2. 10.1186/1477-7517-2-2.
19. Day C., Topp L., Rouen D., Darke S., Hall W., Dolan K. Decreased heroin availability in Sydney in early 2001. Addiction 2003, 98(1):93-95.
20. Degenhardt L., Conroy E., Day C., Gilmour S., Hall W. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence. Drug and Alcohol Dependence 2005, 79(2):129-135. 10.1016/j.drugalcdep.2005.01.018.
21. Degenhardt L., Day C., Dietze P., Pointer S., Conroy E., Collins L., et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005, 100(7):908-920. pii:ADD1094. 10.1111/j.1360-0443.2005.01094.x.
22. Degenhardt L., Roxburgh A., Black E., Bruno R., Campbell G., Kinner S., et al. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review 2008, 27(3):243-252. pii:791757352. 10.1080/09595230801950572.
23. Dietze P., Fitzgerald J. Interpreting changes in heroin supply in Melbourne: Droughts, gluts or cycles?. Drug and Alcohol Review 2002, 21(3):295-303. 10.1080/0959523021000002778.
24. Dwyer R. Privileging pleasure: Temazepam injection in a heroin marketplace. International Journal of Drug Policy 2008, 19(5):367-374. S0955-3959(07)00210-1. 10.1016/j.drugpo.2007.09.004.
25. European Monitoring Centre for Drugs and Drug Addiction Polydrug use: Patterns and responses 2009, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
26. Fast D., Small W., Krusi A., Wood E., Kerr T. 'I guess my own fancy screwed me over': Transitions in drug use and the context of choice among young people entrenched in an open drug scene. BMC Public Health 2010, 10:126. 10.1186/1471-2458-10-126.
27. Gerra G., Bertacca S., Zaimovic A., Pirani M., Branchi B., Ferri M. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts. Substance Use & Misuse 2008, 43(3-4):317-330. 10.1080/10826080701202726.
28. Gibson A., Degenhardt L., Topp L., Day C., Hall W., Dietze P., et al. Global and Australian Heroin Markets: Technical Report No. 67 2003, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
29. Goldsamt L.A., Harocopos A., Kobrak P., Jost J.J., Clatts M.C. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. Journal of Community Health 2010, 35(3):258-267. 10.1007/s10900-010-9231-z.
30. Gossop M., Marsden J., Stewart D., Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction 2003, 98(3):291-303. 10.1046/j.1360-0443.2003.00296.x.
31. Gowing L., Proudfoot H., Henry-Edwards S., Teesson M. ANCD research paper 3: Evidence supporting treatment - The effectiveness of interventions for illicit drug use 2001, Australian National Council on Drugs, Canberra.
32. Guichard A., Guignard R., Michels D., Beck F., Arwidson P., Lert F., et al. Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis. Drug and Alcohol Dependence 2013, 133(1):254-261. 10.1016/j.drugalcdep.2013.04.026.
33. Hall W.D., Ross J.E., Lynskey M.T., Law M.G., Degenhardt L.J. How many dependent heroin users are there in Australia?. Medical Journal of Australia 2000, 173(10):528-531.
34. Hellard M.E., Nguyen O.K., Guy R.J., Jardine D., Mijch A., Higgs P.G. The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users. Australian and New Zealand Journal of Public Health 2006, 30(6):519-525. 10.1111/j.1467-842X.2006.tb00779.x.
35. Horyniak D., Higgs P., Jenkinson R., Degenhardt L., Stoove M., Kerr T., et al. Establishing the Melbourne injecting drug user cohort study (MIX): Rationale, methods, and baseline and twelve-month follow-up results. Harm Reduction Journal 2013, 10(1):11.
36. Iversen J., Topp L., Maher L. Australian NSP Survey: Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program Attendees - National Data Report 1995-2010 2011, The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney.
37. Jofre-Bonet M., Petry N.M. Trading apples for oranges? Results of an experiment on the effects of Heroin and Cocaine price changes on addicts' polydrug use. Journal of Economic Behavior & Organization 2008, 66(2):281-311. 10.1016/j.jebo.2006.05.002.
38. Khobzi N., Strike C., Cavalieri W., Bright R., Myers T., Calzavara L., et al. A qualitative study on the initiation into injection drug use: Necessary and background processes. Addiction Research and Theory 2009, 17(5):546-559.
39. Lankenau S.E., Wagner K.D., Bloom J.J., Sanders B., Hathazi D., Shin C. The first injection event: Differences among heroin, methamphetamine, cocaine and ketamine initiates. Journal of Drug Issues 2010, 40(2):241-262.
40. Larance B., Degenhardt L., Lintzeris N., Bell J., Winstock A., Dietze P., et al. Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence 2011, 118(2-3):265-273. 10.1016/j.drugalcdep.2011.04.002.
41. Lawrinson P., Ali R., Buavirat A., Chiamwongpaet S., Dvoryak S., Habrat B., et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008, 103(9):1484-1492. 10.1111/j.1360-0443.2008.02249.x.
42. Leong M., Murnion B., Haber P.S. Examination of opioid prescribing in Australia from 1992 to 2007. Internal Medicine Journal 2009, 39(10):676-681. 10.1111/j.1445-5994.2009.01982.x.
43. Louie R., Krouskos D., Gonzalez M., Crofts N. Vietnamese speaking injecting drug users in Melbourne: The need for harm reduction programs. Australian and New Zealand Journal of Public Health 1998, 22(4):481-484.
44. Maher L., Sargent P., Higgs P., Crofts N., Kelsall J., Le T.T. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne. Australian and New Zealand Journal of Public Health 2001, 25(1):50-54.
45. Maher L., Swift W., Dawson M. Heroin purity and composition in Sydney, Australia. Drug and Alcohol Review 2001, 20(4):439-448. 10.1080/09595230120092698.
46. Moore T.J., Caulkins J.P., Ritter A., Dietze P., Monagle S., Pruden J. DPMP Monograph No. 09: Heroin markets in Australia: Current understandings and future possibilities. DPMP Monograph Series 2005, Turning Point Alcohol and Drug Centre, Fitzroy.
47. Nicholas R. The impact of social networks and not-for-profit illicit drug dealing on illicit drug markets in Australia: NDLERF Discussion Paper 2008, National Drug Law Enforcement Research Fund, Hobart.
48. Nielsen S., Bruno R., Carruthers S., Fischer S., Lintzeris N., Stoove M. Investigation of pharmaceutical misuse amongst drug treatment clients 2008, Turning Point Alcohol and Drug Centre, Melbourne.
49. Novelli L.A., Sherman S.G., Havens J.R., Strathdee S.A., Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug and Alcohol Dependence 2005, 77(3):303-309. S0376-8716(04)00250-9. 10.1016/j.drugalcdep.2004.08.021.
50. O'Connor L.E., Berry J.W., Morrison A., Brown S. The drug-of-choice phenomenon: Psychological differences among drug users who preferred different drugs. Substance Use & Misuse 1995, 30(5):541-555. 10.3109/10826089509048743.
51. Oliveira M.L., Hacker M.A., Oliveira S.A., Telles P.R., do O K.M., Yoshida C.F., et al. "The first shot": The context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil. Cad Saude Publica 2006, 22(4):861-870. pii:S0102-311X2006000400024, S0102-311X2006000400024.
52. Quinn B., Stoové M., Papanastasiou C., Dietze P. Methamphetamine use in Melbourne, Australia: Baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence. Journal of Substance Use 2013, 18(5):349-362. 10.3109/14659891.2012.675400.
53. Reddel S., Horyniak D., Dietze P., McElwee P. Victorian drug trends 2010: Findings from the illicit drug reporting system (IDRS). Australian Drug Trends Series No. 58 2011, Burnet Institute; Turning Point Alcohol and Drug Centre; National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
54. Ritter A. DPMP Monograph No. 08: A review of approaches to studying illicit drug markets DPMP Monograph series 2005, Turning Point Alcohol and Drug Centre, Fitzroy.
55. Roy E., Haley N., Leclerc P., Cedras L., Boivin J.F. Drug injection among street youth: The first time. Addiction 2002, 97(8):1003-1009.
56. Stafford J., Burns L. Australian drug trends 2010: Findings from the illicit drug reporting system (IDRS). Australian Drug Trends Series No. 55 2011, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
57. Stafford J., Burns L. Australian drug trends 2012: Findings from the illicit drug reporting system (IDRS). Australian Drug Trends Series No. 91 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
58. Stafford J., Sindicich N., Burns L. Australian drug trends 2008: Findings from the illicit drug reporting system (IDRS). Australian Drug Trends No. 19 2009, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
59. Stillwell G., Hunt N., Taylor C., Griffiths P. The modelling of injecting behaviour and initiation into injecting. Addiction Research & Theory 1999, 7(5):447-459. 10.3109/16066359909004398.
60. Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3 years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008, 103(1):80-88. 10.1111/j.1360-0443.2007.02029.x.
61. Topp L., Darke S., Bruno R., Fry C., Hargreaves K., Humeniuk R., et al. Australian drug trends 2000: Findings of the illicit drug reporting system (IDRS). NDARC Monograph No. 47 2001, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
62. Topp L., Day C., Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence 2003, 70(3):275-286.
63. Topp L., Kaye S., Bruno R., Longo M., Williams P., O'Reilly B. Australian drug trends 2001: Findings of the illicit drug reporting system (IDRS). NDARC Monograph 48 2002, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
64. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17(6):887-893. 10.1097/01.aids.0000050859.71999.ae.
65. Vidal-Trecan G.M., Varescon-Pousson I., Boissonnas A. Injection risk behaviors at the first and at the most recent injections among drug users. Drug and Alcohol Dependence 2002, 66(2):107-109. 10.1016/S0376-8716(01)00196-X.
66. Vlahov D., Anthony J.C., Celentano D., Solomon L., Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. American Journal of Drug and Alcohol Abuse 1991, 17(1):39-48.
67. Vlahov D., Fuller C.M., Ompad D.C., Galea S., Des Jarlais D.C. Updating the infection risk reduction hierarchy: Preventing transition into injection. Journal of Urban Health 2004, 81(1):14-19. 10.1093/jurban/jth083.
68. Weatherburn D., Jones C., Freeman K., Makkai T. Supply control and harm reduction: Lessons from the Australian heroin 'drought'. Addiction 2003, 98(1):83.
69. Weatherburn D., Lind B. The impact of law enforcement activity on a heroin market. Addiction 1997, 92(5):557-569.
70. Witteveen E., Van Ameijden E.J., Schippers G.M. Motives for and against injecting drug use among young adults in Amsterdam: Qualitative findings and considerations for disease prevention. Substance Use and Misuse 2006, 41(6-7):1001-1016. pii:L20101L3L45J8666. 10.1080/10826080600669561.